Join
Live feed
·
PRReleasevia Quantisnow
Zealand Pharma A/S logo
Generate Biomedicines Inc. logo

Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZEAL (Zealand Pharma A/S), GENB (Generate Biomedicines Inc.) and more on Quantisnow.